Jane Street Group, LLC Prothena Corp Public LTD CO Transaction History

Jane Street Group, LLC

  • $444 Billion
  • Q4 2024

A detailed history of Jane Street Group, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Jane Street Group, LLC holds 28,700 shares of PRTA stock, worth $446,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,700
Previous 11,500 149.57%
Holding current value
$446,572
Previous $192,000 106.77%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$11.95 - $18.35 $476,996 - $732,458
-39,916 Reduced 41.82%
55,528 $769,000
Q3 2024

Nov 14, 2024
SELL
$16.73 - $24.79 $435,331 - $645,060
-26,021 Reduced 21.42%
95,444 $1.6 Million
Q2 2024

Aug 14, 2024
BUY
$19.54 - $26.15 $1.31 Million - $1.75 Million
67,069 Added 123.3%
121,465 $2.51 Million
Q1 2024

May 15, 2024
SELL
$24.75 - $40.66 $3.24 Million - $5.32 Million
-130,799 Reduced 70.63%
54,396 $1.35 Million
Q4 2023

Feb 14, 2024
BUY
$32.31 - $52.32 $5.78 Million - $9.36 Million
178,939 Added 2860.28%
185,195 $6.73 Million
Q3 2023

Nov 14, 2023
SELL
$47.3 - $70.6 $2.23 Million - $3.33 Million
-47,219 Reduced 88.3%
6,256 $301,000
Q2 2023

Aug 14, 2023
BUY
$48.26 - $78.59 $1.64 Million - $2.68 Million
34,082 Added 175.74%
53,475 $3.65 Million
Q1 2023

May 15, 2023
BUY
$46.97 - $58.27 $910,889 - $1.13 Million
19,393 New
19,393 $939,000
Q2 2022

Aug 16, 2022
BUY
$22.73 - $39.98 $363,680 - $639,680
16,000 Added 174.52%
25,168 $683,000
Q4 2021

Feb 15, 2022
SELL
$42.11 - $73.26 $159,217 - $276,996
-3,781 Reduced 29.2%
9,168 $453,000
Q3 2021

Nov 16, 2021
BUY
$48.2 - $78.89 $624,141 - $1.02 Million
12,949 New
12,949 $922,000
Q4 2020

Feb 17, 2021
SELL
$10.12 - $13.94 $238,751 - $328,872
-23,592 Closed
0 $0
Q3 2020

Nov 17, 2020
SELL
$9.93 - $13.47 $211,588 - $287,018
-21,308 Reduced 47.46%
23,592 $236,000
Q2 2020

Aug 17, 2020
BUY
$9.56 - $12.51 $429,244 - $561,699
44,900 New
44,900 $470,000
Q1 2019

May 16, 2019
SELL
$10.32 - $14.49 $176,585 - $247,938
-17,111 Closed
0 $0
Q4 2018

Feb 15, 2019
BUY
$8.73 - $13.74 $149,379 - $235,105
17,111 New
17,111 $176,000
Q3 2018

Nov 14, 2018
SELL
$12.7 - $15.79 $132,295 - $164,484
-10,417 Closed
0 $0
Q2 2018

Aug 15, 2018
SELL
$10.99 - $44.21 $3,439 - $13,837
-313 Reduced 2.92%
10,417 $152,000
Q1 2018

May 15, 2018
BUY
$27.95 - $45.04 $299,903 - $483,279
10,730 New
10,730 $394,000
Q4 2017

Feb 15, 2018
SELL
$35.44 - $63.76 $221,039 - $397,671
-6,237 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$53.83 - $67.75 $335,737 - $422,556
6,237
6,237 $404,000

Others Institutions Holding PRTA

# of Institutions
198
Shares Held
44.5M
Call Options Held
601K
Put Options Held
259K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $730M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email